Eris Lifesciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	673	2,005	13,389	560.22	508.7
Short-Term Investments	-	50	-	0.02	619.01
Trading Asset Securities	-	-	-	300.05	995.46
Cash & Short-Term Investments	673	2,055	13,389	860.29	2,123
Cash Growth	-67.25%	-84.65%	1456.29%	-59.48%	65.11%
Accounts Receivable	6,803	4,586	4,220	2,927	1,610
Other Receivables	90.8	1,092	1,435	1,617	244.69
Receivables	7,422	5,736	5,710	4,584	2,084
Inventory	4,368	3,348	1,890	1,314	1,179
Prepaid Expenses	-	200.4	256.2	172.83	214.39
Other Current Assets	2,936	890.6	1,775	715.84	672.23
Total Current Assets	15,399	12,230	23,020	7,647	6,273
Property, Plant & Equipment	8,798	7,288	5,583	3,774	1,919
Long-Term Investments	615.6	622	157.3	68.77	4,208
Goodwill	9,120	9,120	8,672	3,318	934.74
Other Intangible Assets	35,672	37,327	29,134	18,806	6,596
Long-Term Deferred Tax Assets	2,429	2,890	3,070	2,739	2,431
Other Long-Term Assets	1,610	843.7	758.7	309.96	330.82
Total Assets	73,655	70,332	70,405	36,673	22,721
Accounts Payable	3,297	3,324	2,189	1,248	1,178
Accrued Expenses	-	2,032	972.6	288.05	209.65
Short-Term Debt	-	3,966	17,488	701.22	92.7
Current Portion of Long-Term Debt	13,539	2,876	3,319	1,306	-
Current Portion of Leases	87.5	120.5	89.8	77.21	40.02
Current Income Taxes Payable	777.6	436.1	395.9	39	69.97
Current Unearned Revenue	-	6.3	44.5	37.7	5.65
Other Current Liabilities	3,071	1,054	821	735.88	400.73
Total Current Liabilities	20,771	13,814	25,321	4,432	1,996
Long-Term Debt	9,558	17,375	6,545	6,444	450
Long-Term Leases	401.9	442.1	370.2	389.74	353.94
Long-Term Unearned Revenue	48.7	108.7	76.6	87.39	56.88
Pension & Post-Retirement Benefits	-	219.2	96.1	38.81	8.92
Long-Term Deferred Tax Liabilities	3,051	5,185	5,344	2,576	460.94
Other Long-Term Liabilities	867.8	470.6	431.1	497.39	312.22
Total Liabilities	34,699	37,614	38,184	14,467	3,639
Common Stock	138.5	136.2	136	135.99	135.93
Additional Paid-In Capital	-	293.4	180.7	151.01	106.13
Retained Earnings	-	27,928	25,409	21,559	18,737
Comprehensive Income & Other	38,888	186.4	135.7	113.58	104.52
Total Common Equity	39,027	28,544	25,862	21,960	19,083
Minority Interest	-70.1	4,174	6,359	246.89	-1.08
Shareholders' Equity	38,957	32,718	32,221	22,207	19,082
Total Liabilities & Equity	73,655	70,332	70,405	36,673	22,721
Total Debt	23,586	24,779	27,813	8,918	936.66
Net Cash (Debt)	-22,913	-22,725	-14,424	-8,058	1,187
Net Cash Growth	-	-	-	-	5.46%
Net Cash Per Share	-167.40	-166.73	-105.93	-59.18	8.73
Filing Date Shares Outstanding	136.7	136.16	136.03	135.99	135.93
Total Common Shares Outstanding	136.7	136.16	136.03	135.99	135.93
Working Capital	-5,373	-1,584	-2,300	3,215	4,277
Book Value Per Share	285.48	209.63	190.12	161.48	140.39
Tangible Book Value	-5,765	-17,903	-11,943	-164.57	11,552
Tangible Book Value Per Share	-42.17	-131.48	-87.80	-1.21	84.99
Land	-	1,175	490.8	229.18	195.33
Buildings	-	2,464	1,973	1,240	326
Machinery	-	4,221	3,525	2,268	1,299
Construction In Progress	-	667.4	190.6	213.78	240.04
Leasehold Improvements	-	116.3	109.9	92.81	84.8